These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7826924)

  • 21. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Mohamed SM; Aagaard T; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
    Brachytherapy; 2015; 14(1):56-61. PubMed ID: 25176182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanded pelvic radiotherapy fields for treatment of local-regionally advanced carcinoma of the cervix: outcome and complications.
    Greer BE; Koh WJ; Stelzer KJ; Goff BA; Comsia N; Tran A
    Am J Obstet Gynecol; 1996 Apr; 174(4):1141-9; discussion 1149-50. PubMed ID: 8623841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic irradiation of para-aortic lymph nodes in carcinoma of the uterine cervix. A prospective randomized study.
    Chatani M; Matayoshi Y; Masaki N; Narumi Y; Teshima T; Inoue T
    Strahlenther Onkol; 1995 Nov; 171(11):655-60. PubMed ID: 7502230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose rate correction in medium dose rate brachytherapy for carcinoma cervix.
    Patel FD; Negi PS; Sharma SC; Kapoor R; Singh DP; Ghoshal S
    Radiother Oncol; 1998 Dec; 49(3):317-23. PubMed ID: 10075265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
    Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
    N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
    Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
    Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables.
    Ferrigno R; Campos de Oliveira Faria SL; Weltman E; Salvajoli JV; Segreto RA; Pastore A; Nadalin W
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):695-706. PubMed ID: 12573757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose rate brachytherapy in the treatment of carcinoma of uterine cervix: twenty-year experience with cobalt after-loading system.
    Mosalaei A; Mohammadianpanah M; Omidvari S; Ahmadloo N
    Int J Gynecol Cancer; 2006; 16(3):1101-5. PubMed ID: 16803492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of primary invasive cervical cancer. Considerations on 997 consecutive cases.
    Bianchi UA; Sartori E; Pecorelli S; Cavagnini A; Baroncelli G; La Face B; Gastaldi A
    Eur J Gynaecol Oncol; 1988; 9(1):47-53. PubMed ID: 3345784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of recurrence of squamous cell carcinoma of the uterine cervix after definitive radiation therapy alone: patterns of recurrence, latent periods, and prognosis.
    Sakurai H; Mitsuhashi N; Takahashi M; Akimoto T; Muramatsu H; Ishikawa H; Imai R; Yamakawa M; Hasegawa M; Niibe H
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1136-44. PubMed ID: 11483322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Carcinoma of the uterine cervix stage III and IV--treatment, results and complications (author's transl)].
    Kucera H; Gerstner G; Weghaupt K
    Geburtshilfe Frauenheilkd; 1982 Jun; 42(6):457-61. PubMed ID: 6809523
    [No Abstract]   [Full Text] [Related]  

  • 34. Survival and complications in cervical cancer treated by pelvic and extended field radiation after paraaortic lymphadenectomy.
    Delgado G; Caglar H; Walker P
    AJR Am J Roentgenol; 1978 Jan; 130(1):141-3. PubMed ID: 413399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined radiotherapy and hysterectomy in the treatment of high risk stage II invasive carcinoma of the uterine cervix.
    Srisupundit S; Tangtrakul S; Linasmita V; Bullangpoti S; Kraiphibul P; Pojchanugool L
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():256-61. PubMed ID: 7661593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
    Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results of treatment of cervical malignancies at the Medical Department of the Friedrich Schiller University in Jena 1965-1976. III. Comparison of results of telecobalt postoperative radiotherapy with conventional roentgen irradiation].
    Kloetzer KH; Sommer H; Kob D; Nöschel H
    Zentralbl Gynakol; 1984; 106(3):170-4. PubMed ID: 6702347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot study of concomitant boost accelerated superfractionated radiotherapy for stage III cancer of the uterine cervix.
    Kavanagh BD; Gieschen HL; Schmidt-Ullrich RK; Arthur D; Zwicker R; Kaufman N; Goplerud DR; Segreti EM; West RJ
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):561-8. PubMed ID: 9231680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High dose rate cobalt-60 afterloading intracavitary therapy of uterine cervical carcinomas in Srinagarind hospital - analysis of complications.
    Pesee M; Krusun S; Padoongcharoen P
    Asian Pac J Cancer Prev; 2010; 11(2):491-4. PubMed ID: 20843138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.